Search the Newsreel

Janus Henderson Group PLC Trims Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

Janus Henderson Group PLC significantly reduced its stake in Guardian Pharmacy Services, Inc. by 72.1% in the first quarter, selling 33,674 shares and retaining 13,000 shares valued at $490,000. Despite this reduction and a recent 6.3% trading decline, Guardian Pharmacy Services reported strong quarterly …

Dimensional Fund Advisors LP Acquires 139,070 Shares of Guardian Pharmacy Services, Inc. $GRDN

Dimensional Fund Advisors LP significantly increased its stake in Guardian Pharmacy Services (NYSE:GRDN) by 200%, acquiring an additional 139,070 shares to bring its total to 208,594 shares valued at $7.855 million. Other institutional investors also boosted their holdings, with Jennison Associates LLC increasing its …

Guardian Pharmacy Services (GRDN) Could Be 12% Undervalued Following Raised Guidance and Q2 Results

Guardian Pharmacy Services (GRDN) Stock Rises On Stronger Margins And Raised Guidance

Guardian Pharmacy Services (GRDN) As Strong Results And Higher Outlook Recast The Valuation Story

Earnings Beat: Guardian Pharmacy Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Guardian Pharmacy Services, Inc. (NYSE:GRDN) recently surpassed analyst forecasts with strong Q2 results, reporting revenues of US$352m (3.3% above estimates) and EPS of US$0.34 (51% ahead of expectations). Following these results, analysts have updated their models, maintaining revenue estimates for 2026 at US$1.44b but …

Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen

Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint

Guardian Pharmacy Services (GRDN) saw its stock rise by 10.9% after reporting strong second-quarter 2026 results, including US$351.77 million in sales and US$21.87 million in net income. The company also raised its full-year 2026 revenue guidance to US$1.43 billion–US$1.45 billion and is continuing its …

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services reported a 2% year-over-year revenue growth to $351.2 million and a 19% increase in adjusted EBITDA to $29.7 million for Q2, despite profitability pressure from Inflation Reduction Act drug pricing reductions. The company raised its 2026 revenue and adjusted EBITDA outlook …

Guardian Pharmacy Services (NYSE:GRDN) Posts Earnings Results, Beats Estimates By $0.03 EPS

Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF)

Guardian Pharmacy Services, Inc. Stock 12‑Month Price Target Raised to $48.83, Implies 24% Upside

Guardian Pharmacy Services, Inc. (GRDN) has seen its average 12-month price target raised to $48.83 from $47 by 6 analysts, implying a 24% potential upside from its Aug. 6 closing price. All 6 covering analysts maintain a "Buy" rating for the stock.

Guardian Pharmacy Services (NYSE:GRDN) Stock Forecast & Analyst Predictions

Guardian Pharmacy Services (NYSE:GRDN) is projected to see annual earnings growth of 15.4% and revenue growth of 5.7%, with EPS expected to increase by 14.8%. Recent updates include beating analyst forecasts, raising full-year 2026 earnings guidance, and acquiring Wellness Concepts to expand its footprint. …

Guardian Pharmacy Services stock hits all-time high at 44.47 USD

Guardian Pharmacy Services Inc. has seen its stock reach an all-time high of $44.47, pushing its market capitalization to $2.5 billion. Despite a remarkable 118.93% increase in stock value over the past year, InvestingPro analysis suggests the stock might be overvalued relative to its …

Guardian Pharmacy Services (NYSE:GRDN) Sets New 12-Month High After Better-Than-Expected Earnings

Guardian Pharmacy Services shares rise 3% on guidance beat

Guardian Pharmacy Services (NYSE:GRDN) reported strong second-quarter results, exceeding analyst expectations for guidance. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, leading to a 3.22% rise in pre-market trading. Despite some impact from IRA-related pricing reductions, the underlying business momentum remained …

Is Guardian Pharmacy (GRDN) Using Tech-Driven Kentucky Expansion to Redefine Its Long-Term Care Edge?

Guardian Pharmacy Services has expanded its presence into Kentucky with a new technology-driven long-term care pharmacy in Lexington, aimed at serving various care settings. This expansion is part of Guardian's strategy to scale its tech-enabled pharmacy network, with the company reaffirming its 2026 revenue …

Guardian Pharmacy Services, Inc. 3Q 2026: Revenue $351.8M, EPS $0.34— 10-Q Summary

Guardian Pharmacy Services, Inc. (GRDN) reported its third-quarter 2026 results, showing revenue of $351.8 million and diluted EPS of $0.34. The company experienced modest top-line growth and stronger profit performance year-over-year, driven by acquisitions, increased prescription volume, and improved gross margins. Guardian Pharmacy Services …

Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates

Guardian Pharmacy: Q2 Earnings Snapshot

Guardian Pharmacy Services Inc. (GRDN) reported a second-quarter profit of $21.9 million, translating to 34 cents per share, or 29 cents per share when adjusted for one-time gains and costs. This result surpassed Wall Street expectations. The company, which provides pharmacy services to long-term …

Earnings call transcript: Guardian Pharmacy lifts 2026 outlook on Q2 margin gains

Guardian Pharmacy Services reported Q2 results showing a 2% revenue increase to $351.2 million and a 19% adjusted EBITDA increase to $29.7 million, despite pricing pressure from the Inflation Reduction Act. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, signaling stronger …

Guardian Pharmacy (NYSE: GRDN) lifts 2026 revenue and EBITDA outlook

Guardian Pharmacy Services (NYSE: GRDN) reported its Q2 2026 financial results, showing increased revenue and net income, and subsequently raised its full-year 2026 revenue and Adjusted EBITDA guidance. The company also announced the acquisition of Wellness Concepts, a long-term care pharmacy in Virginia, and …

First Trust Advisors LP Purchases Shares of 93,677 Guardian Pharmacy Services, Inc. $GRDN

Guardian Pharmacy Services opens long-term care (LTC) pharmacy in Lexington

Guardian Pharmacy Services has opened its first physical location in Kentucky, Guardian Pharmacy of Kentucky, in Lexington. This new state-of-the-art facility will serve residents in various long-term care communities across the state, enhancing service delivery and providing specialized medication management. The expansion aims to …

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Guardian Pharmacy Services (GRDN) Projected to Release Earnings on Thursday

Guardian Pharmacy Services Inc (GRDN) Cash Flow

This article provides a detailed cash flow statement for Guardian Pharmacy Services Inc (GRDN), covering quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions explaining key cash flow metrics like operating cash flow, investing cash flow, financing …

GRDN|Guardian Pharmacy Services Inc|Price:41.000|Chg%:-0.860

TradingKey provides a comprehensive stock analysis of Guardian Pharmacy Services Inc (GRDN), indicating strong fundamentals, high growth potential, and a "Strong Buy" analyst rating with a target price of $47.00. The company's valuation is considered fairly valued within the Food & Drug Retailing industry, …

Guardian Pharmacy Services Inc (GRDN) Institutional Confidence

Guardian Pharmacy Services Inc (GRDN) has an institutional shareholding score of 3.00, placing it 15th out of 29 in the Food & Drug Retailing industry. The institutional shareholding proportion recently saw a quarter-over-quarter decrease of 17.27%, now standing at 49.32%. James Simons is noted …

Guardian Pharmacy Services Inc (GRDN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

This article from TradingKey provides a revenue breakdown for Guardian Pharmacy Services Inc (GRDN). However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. The page displays basic stock information including market …

GRDN|Guardian Pharmacy Services Inc|Price:39.400|Chg%:-0.370

Guardian Pharmacy Services Inc. (GRDN) shows strong fundamentals with high revenue and profit growth over the past three years, despite its stock trading sideways recently. Analysts maintain a "Strong Buy" rating with a target price of $47.00, representing a 14.89% upside. However, the company's …

Bessemer Group Inc. Purchases Shares of 78,656 Guardian Pharmacy Services, Inc. $GRDN

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced it will release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call at 4:30 p.m. Eastern Time to discuss these results. The company, a leading long-term …